Sirtex Medical Ltd (SRX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sirtex Medical Ltd (SRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12412
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin microspheres reside in the small blood vessels of the tumor where they destroy it from the inside while saving the surrounding healthy tissue. Sirtex Medical conducts studies, which include SIRFLOX and FOXFIRE Global for liver metastases, and RESIRT for primary renal cell carcinoma. The company has operations in Australia, New Zealand, Singapore, Germany, the US, Canada, and others. Sirtex Medical is headquartered in North Sydney, New South Wales, Australia.

Sirtex Medical Ltd (SRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirtex Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sirtex Medical Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
CDH Investments and China Grand Pharma Plan to Acquire Sirtex Medical for USD1.43 Billion 11
Partnerships 13
Sirtex Medical and Gaurbet Enter into Collaboration Agreement 13
Sirtex Enters Into Research Agreement With SingHealth For Cancer Therapies 14
Acquisition 15
Varian Medical Systems to Acquire Sirtex Medical for USD1.285 Billion 15
Sirtex Medical Ltd – Key Competitors 17
Sirtex Medical Ltd – Key Employees 18
Sirtex Medical Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Strategy And Business Planning 21
Jun 28, 2017: Sirtex Resets Business With Write Off Of Intangibles And Restructure 21
Financial Announcements 23
Aug 29, 2018: Sirtex records full year NPAT of $41.5 million 23
Feb 21, 2018: Sirtex records 1H18 NPAT of $ 23.6 million 25
Aug 23, 2017: Sirtex Records Underlying Full Year NPAT of $42.4 Million 26
Feb 22, 2017: Sirtex Records First Half NPAT of $20.8 Million 30
Corporate Communications 33
Sep 20, 2017: Mr Richard Hill to Retire as Chairman at Upcoming AGM 33
Sep 13, 2017: Helen Kurincic Joins the Sirtex Board as a Non-Executive Director 34
Jun 16, 2017: Sirtex CEO Andrew McLean Joins the Board of Directors 35
May 24, 2017: Sirtex Appoints Andrew McLean as Chief Executive Officer 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirtex Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirtex Medical Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sirtex Medical Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CDH Investments and China Grand Pharma Plan to Acquire Sirtex Medical for USD1.43 Billion 11
Sirtex Medical and Gaurbet Enter into Collaboration Agreement 13
Sirtex Enters Into Research Agreement With SingHealth For Cancer Therapies 14
Varian Medical Systems to Acquire Sirtex Medical for USD1.285 Billion 15
Sirtex Medical Ltd, Key Competitors 17
Sirtex Medical Ltd, Key Employees 18
Sirtex Medical Ltd, Subsidiaries 19

List of Figures
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sirtex Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sirtex Medical Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sirtex Medical Ltd (SRX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ithaca Energy Ltd:企業の戦略的SWOT分析
    Ithaca Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AliveCor Inc:医療機器:M&Aディール及び事業提携情報
    Summary AliveCor Inc (AliveCor) is a heart rate measuring technology provider. The company offers kardia mobile and kardia application. It provides medical-grade EKG in just thirty seconds. AliveCor’s kardia offers easy to use, affordable, portable and trusted. The company track data over time and m …
  • Fluidra, S.A. (FDR):企業の財務・戦略的SWOT分析
    Fluidra, S.A. (FDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • OpGen Inc (OPGN)-医療機器分野:企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Transfield Holdings Pty Ltd:企業の戦略的SWOT分析
    Transfield Holdings Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sony Corp (6758):電力:M&Aディール及び事業提携情報
    Summary Sony Corporation (Sony) is a manufacturer of electronic equipment, semiconductors, medical related equipment, instruments, and devices. The company’s products comprises televisions, mobile phones, music systems, cameras, game consoles and software, semiconductors, batteries and other electro …
  • AnGes Inc (4563):医療機器:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • Kyowa Exeo Corporation:企業の戦略・SWOT・財務情報
    Kyowa Exeo Corporation - Strategy, SWOT and Corporate Finance Report Summary Kyowa Exeo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bank Muscat:企業の戦略・SWOT・財務分析
    Bank Muscat - Strategy, SWOT and Corporate Finance Report Summary Bank Muscat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sprott Resource Holdings Inc. (SRHI):企業の財務・戦略的SWOT分析
    Sprott Resource Holdings Inc. (SRHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fresenius SE & Co KGaA (FRE)-医療機器分野:企業M&A・提携分析
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • Rafa Laboratories Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Rafa Laboratories Ltd (Rafa) is a pharmaceutical company that manufactures and distributes medicines and consumer health products. The company offers prescription, over-the-counter medicines, proprietary formulations, generic formulations and consumer health products. It offers scale-up and …
  • Peptron Inc (087010):製薬・医療:M&Aディール及び事業提携情報
    Summary Peptron Inc (Peptron) is a developer and manufacturer of peptide and life science medicines. The company develops SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation. It provides peptide synthesis service, express serv …
  • Booz Allen Hamilton Holding Corporation (BAH):企業の財務・戦略的SWOT分析
    Booz Allen Hamilton Holding Corporation (BAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Warp Drive Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Warp Drive Bio Inc (Warp Drive) is a natural products provider. The company utilizes the proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART platform offers solutions to the pharmaceutical opportunities. Warp Drive's integr …
  • House Foods Group Inc:企業の戦略・SWOT・財務分析
    House Foods Group Inc - Strategy, SWOT and Corporate Finance Report Summary House Foods Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆